Form 4: ScanSource Executive Sells Shares Under 10b5-1 Plan
Insider Transaction Report
ScanSource's SEVP & CIO, Rachel Hayden, reported sales of common stock totaling 1,913 shares and tax-related dispositions of 381 shares.
Summary
- Rachel Hayden, SEVP & CIO of ScanSource, Inc. (SCSC), reported changes in her beneficial ownership of common stock.
- On August 27, 2025, 381 shares of common stock were disposed of at a price of $44.69 per share to satisfy tax withholding obligations upon the vesting of restricted stock units. This was a non-market transaction.
- On August 28, 2025, 1,080 shares of common stock were sold at $44.69 per share.
- On August 29, 2025, an additional 833 shares of common stock were sold at $44.36 per share.
- The sales on August 28 and August 29, 2025, totaling 1,913 shares, were executed pursuant to a Rule 10b5-1 Sales Plan adopted by Ms. Hayden on March 20, 2025.
- Following these transactions, Ms. Hayden beneficially owns 10,855 shares of ScanSource common stock directly.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transactions are routine insider sales conducted under a pre-arranged 10b5-1 plan, which is a common practice for executives managing their equity compensation and personal finances. It does not inherently signal a positive or negative outlook on the company's future performance.
Positives
- The sales of common stock were conducted under a pre-arranged Rule 10b5-1 Sales Plan, indicating a structured and compliant approach to insider transactions rather than opportunistic selling.
Negatives
- Insider selling, even when pre-planned, can sometimes be perceived by the market as a lack of confidence, although this is not necessarily the case with 10b5-1 plans.
Future Outlook
No forward-looking statements or guidance are provided in this insider transaction report.
Management Comments
- Shares were withheld in satisfaction of tax withholding obligations upon vesting of restricted stock units, which is a non-market transaction.
- Sales of common stock were executed pursuant to a Rule 10b5-1 Sales Plan adopted by the reporting person on March 20, 2025.
Industry Context
This filing is specific to an individual executive's stock transactions and does not provide broader industry context or trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Policy Implementation | The reporting person adopted a Rule 10b5-1 Sales Plan on March 20, 2025, which allows insiders to pre-arrange sales of company stock to avoid accusations of trading on material non-public information. | 03/20/2025 | Enhances corporate governance by providing a structured and compliant framework for insider stock sales, reducing potential for perceived conflicts of interest. |
Stakeholder Impact
- Shareholders: May view the pre-planned sales as a routine part of executive compensation management, or potentially as a minor signal of an executive diversifying their holdings. The impact is generally limited given the pre-planned nature.
Key Dates
| Date | Description |
|---|---|
| 03/20/2025 | Date Reporting Person adopted the Rule 10b5-1 Sales Plan. |
| 08/27/2025 | Date of disposition of shares for tax withholding obligations. |
| 08/28/2025 | Date of sale of common stock under 10b5-1 plan. |
| 08/29/2025 | Date of sale of common stock under 10b5-1 plan and filing date of the Form 4. |
Recommendation
holdThe reported transactions are routine insider sales executed under a pre-arranged Rule 10b5-1 plan. Such sales are typically for personal financial planning and do not usually reflect a change in the executive's outlook on the company's fundamentals. Therefore, this filing alone does not provide sufficient new information to warrant a change in investment recommendation, suggesting a 'hold' position is appropriate based solely on this report.
Keywords
ScanSource, SCSC, Insider Trading, Form 4, Stock Sale, Rachel Hayden, 10b5-1 Plan, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.